Table 4.

Depression and long-term care facility admissions: sample characteristics before and after propensity score matching

	Panel A: Depression
	Before Matching			After Matching
	Anti-VEGF			Anti-VEGF
Covariate	Therapy (treatment)	No treatment (control)	Standardized difference	Therapy (treatment)	No treatment	Standardized
Age	81.09	80.60	7.27	81.10	81.12	−0.36
Male	0.35	0.35	1.19	0.35	0.34	2.57
Black	0.01	0.02	−6.67	0.01	0.01	2.18
Charlson	2.02	2.13	−5.45	2.02	1.92	4.88
Diabetes mellitus	0.31	0.33	−4.99	0.31	0.29	4.75
Diabetic retinopathy	0.06	0.07	−4.00	0.06	0.05	4.45
Glaucoma	0.25	0.29	−7.26	0.25	0.25	1.67
Cataract	0.64	0.62	3.08	0.64	0.64	0.28
Other eye complications	0.22	0.18	9.78	0.22	0.20	5.47
			N = 15,561			N = 13,258
	Panel B: Long-term care facility
	Before Matching			After Matching
	Anti-VEGF			Anti-VEGF
Covariate	Therapy (treatment)	No treatment (control)	Standardized difference	Therapy (treatment)	No treatment (control)	Standardized difference
Age	80.53	79.85	10.43	80.55	80.58	−0.54
Male	0.36	0.35	0.83	0.36	0.35	1.77
Black	0.01	0.02	−7.47	0.01	0.01	1.01
Charlson	1.92	1.98	−3.11	1.92	1.82	5.05
Diabetes mellitus	0.30	0.31	−3.40	0.30	0.27	5.88
Diabetic retinopathy	0.06	0.07	−4.43	0.06	0.04	6.32
Glaucoma	0.25	0.29	−8.03	0.25	0.25	−0.22
Cataract	0.65	0.64	2.92	0.65	0.66	−1.13
Other eye complications	0.22	0.19	9.42	0.22	0.21	4.56
			N = 14,300			N = 12,282